Specify a stock or a cryptocurrency in the search bar to get a summary
Nexstim Oyj
NXTMHNexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's navigated transcranial magnetic stimulation (nTMS) technology utilizes 3D navigation for providing accurate and personalized targeting of the TMS to the specific areas of the brain. It also offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depressive disorder (MDD) and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily markets and sells its diagnostics systems to universities and teaching hospitals. Nexstim Plc was incorporated in 2000 and is headquartered in Helsinki, Finland. Address: ElimAeenkatu 9 B, Helsinki, Finland, 00510
Analytics
WallStreet Target Price
3.17 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NXTMH
Dividend Analytics NXTMH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NXTMH
Stock Valuation NXTMH
Financials NXTMH
Results | 2019 | Dynamics |